The RenataDX™ Screening System is a fully integrated flow-injection tandem mass spectrometry (FIA-MS/MS) IVD system for high-throughput dried blood spot analysis that delivers a robust and streamlined platform with the familiar workflow you rely on and provides:
Our Clinical Services program also provides priority service to minimize any disruptions.
The RenataDX Screening System delivers high performance with complete flexibility, ease of use, and fast data acquisitions. All this in a compact footprint for screening dried blood spots and other human biological matrices. Incorporate this IVD medical device into your clinical screening workflow for trusted and reliable performance.
System components include the 3777C IVD Sample Manager, ACQUITY™ UPLC™ I-Class IVD Binary Solvent Manager, and Xevo™ TQD IVD Mass Spectrometer that fits easily on to your benchtop. Fully optimized for diagnostic screening, the RenataDX Screening System also includes:
MassLynx™ (IVD) Software streamlines your data workflow with integrated data acquisition, processing, and reporting through laboratory information management systems (LIMS) and third-party middleware applications.
The IonLynx™ Application Manager can run simultaneously with data collection, meaning your results can arrive in real time. User-definable reports ensure your results are presented exactly as you want them consistently. Applying MassLynx Basic Security, your results can have enhanced security and traceability.
Customizable IonLynx Application Manager browser.
Due to its open-platform design, the RenataDX Screening System can be adapted to your laboratory workflow.
Robust and reproducible data
High-throughput, routine operation complex matrices such as dried blood spots are uncompromised with low carryover and high reproducibility, providing you with the highest confidence that your results will arrive on-time, every time.
For in vitro diagnostic use. Not available in all countries. For information on availability, please contact your local representative.
Flow Injection Analysis Tandem Mass Spectrometry (FIA-MS/MS) in the Clinical Laboratory: Lessons from Newborn Screening Ontario (NSO)